/
/
/

Glaxosmithkline Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)2,840.90
Volume (₹)38,428.00
High (₹)2,863.50
Upper Circuit3,409.00
Low (₹)2,793.90
Lower Circuit2,272.80
Prev Close2,840.90
52W High (₹)3,120.70
Price2,818.90
52W Low (₹)2,088.10

Share Market Cap & Key Ratios Overview

M.Cap (₹)48124.90 Cr
Div. Yield (%)2.01
PE Ratio45.05
Debt to Equity0.00
Price to Book16.94
Book Value134.77
EPS (TTM)63.05
Face Value10.00
ROE (%)48.76

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
AUROPHARMANSE
DRREDDYNSE
LUPINNSE
MANKINDNSE
GLAXONSE
LTP
1W Low
1W High
Market cap (₹)
1840-55 (-2.90%)
1834
1907.80
4,47,236Cr
9322+7 (0.08%)
9119.50
9615
2,49,673Cr
4965.5+51.5 (1.05%)
4823
5000
1,87,460Cr
1119.1-37.8 (-3.27%)
1104.60
1167.70
1,11,521Cr
1366-29 (-2.08%)
1347.70
1398.40
1,11,484Cr
1969+92.3 (4.92%)
1832.70
1981.80
1,04,604Cr
1679.8+19.8 (1.19%)
1646
1704
96,031Cr
1165.5+21.3 (1.86%)
1130
1182
95,220Cr
2095-10 (-0.48%)
2058
2135.50
94,883Cr
2280-38 (-1.64%)
2222
2331.60
92,770Cr
2818.9-138.9 (-4.70%)
2793.90
3075
48,125Cr

Key Highlights of Glaxosmithkline Pharmaceuticals Ltd Balance Sheet

Glaxosmithkline Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹169.41Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹169.41Cr, and the reserves and surplus of the company is ₹2087.47Cr.

The company has its non-current liabilities with total liabilities of ₹4141.3Cr as of 2026-03-31.

The current liabilities are ₹1757.11Cr as of 2026-03-31. At the same time, current assets are ₹3543.12Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹25.36Cr and tangible assets of ₹280.07Cr, provided in the Glaxosmithkline Pharmaceuticals Ltd financial statements.